Biograil ApS announced that it has received a round of funding on April 5, 2024. The transaction included participation from new investors, Roquette Ventures, Eli Lilly and Company, returning investors, High-Tech Gründerfonds Management GmbH, Megatrend Invest A/S, Sanner Ventures GmbH, Verve Capital Partners AG, and Evonik Venture Capital GmbH.
Market Closed -
Other stock markets
|
After market 04:16:35 pm | |||
737.2 USD | +0.50% | 735 | -0.30% |
10:11pm | US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week | MT |
09:47pm | Equities Higher as Traders Await This Week's Key Earnings, Fed Decision | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B | |
-10.91% | 144B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Biograil ApS announced that it has received funding from a group of investors